Retrieve available abstracts of 82 articles: HTML format
Single Articles
July 2025
SUN Y, Yang C, Liu P, Cong Z, et al Novel insights into immune checkpoints in HIV/SHIV infection: from
SHIV(SF162P3)-infected elite controllers to therapeutic strategy.
J Virol. 2025 Jul 10:e0078525. doi: 10.1128/jvi.00785. PubMedAbstract available
JANSSENS J, Isbell C, Kim SJ, Wedrychowski A, et al Differential decreases in various HIV DNA regions and HIV transcripts after ART
initiation during chronic infection.
J Virol. 2025 Jul 8:e0068325. doi: 10.1128/jvi.00683. PubMedAbstract available
TORGBOR C, Thorley-Lawson DA, Moormann AM Epstein-Barr virus-infected tonsillar marginal zone B cells in vivo as a
precursor for immunosuppression-related B-cell lymphoma.
J Virol. 2025 Jul 8:e0105124. doi: 10.1128/jvi.01051. PubMedAbstract available
June 2025
ISMAIL SD, Sebaa S, Abrahams B, Nason MC, et al The role of Nef in the long-term persistence of the replication-competent HIV
reservoir in South African women.
J Virol. 2025 Jun 24:e0021725. doi: 10.1128/jvi.00217. PubMedAbstract available
COTTIGNIES-CALAMARTE A, Marteau F, He F, Belouzard S, et al Direct pharmacological AMPK activation inhibits mucosal SARS-CoV-2 infection by
reducing lipid metabolism, restoring autophagy flux and the type I IFN response.
J Virol. 2025 Jun 12:e0039425. doi: 10.1128/jvi.00394. PubMedAbstract available
SCHIFFER JT, Mudd JC, Antar AAR, Spivak AM, et al Applications and limitations of the passenger hypothesis for HIV reservoir
persistence and cure.
J Virol. 2025 Jun 4:e0071425. doi: 10.1128/jvi.00714. PubMedAbstract available
May 2025
SUTAR J, Jayal P, Mullick R, Chaudhary S, et al Distinct region-specific neutralization profiles of contemporary HIV-1 clade C
against best-in-class broadly neutralizing antibodies.
J Virol. 2025 May 16:e0000825. doi: 10.1128/jvi.00008. PubMedAbstract available
GREBER UF Clicking viruses-with chemistry toward mechanisms in infection.
J Virol. 2025 May 14:e0047125. doi: 10.1128/jvi.00471. PubMedAbstract available
NIKOLAITCHIK OA, Chameettachal A, Islam S, Cheng Z, et al How to recover from a bad start: adaptation of HIV-1 transcription start site
mutants during serial passaging in culture.
J Virol. 2025 May 7:e0015925. doi: 10.1128/jvi.00159. PubMedAbstract available
April 2025
FAN T-J, Xie C, Li L, Jin X, et al HIV-1 Nef activates proviral DNA transcription by recruiting Src kinase to
phosphorylate host protein Nef-associated factor 1 to compromise its viral
restrictive function.
J Virol. 2025 Apr 24:e0028025. doi: 10.1128/jvi.00280. PubMedAbstract available
RADFORD CE, Bloom JD Comprehensive maps of escape mutations from antibodies 10-1074 and 3BNC117 for
Envs from two divergent HIV strains.
J Virol. 2025 Apr 22:e0019525. doi: 10.1128/jvi.00195. PubMedAbstract available
LARROUS P, Garnier C, Morel M, Martin MM, et al Deciphering lentiviral Vpr/Vpx determinants required for HUSH and SAMHD1
antagonism highlights the molecular plasticity of these evolutionary conflicts.
J Virol. 2025 Apr 22:e0019825. doi: 10.1128/jvi.00198. PubMedAbstract available
MOORAD R, Peng A, Landis J, Pluta LJ, et al Genome evolution of Kaposi sarcoma-associated herpesvirus (KSHV).
J Virol. 2025 Apr 16:e0195024. doi: 10.1128/jvi.01950. PubMedAbstract available
GROVES NS, Clark AR, Aguilar RS, Hikichi Y, et al A monomeric envelope glycoprotein cytoplasmic tail is sufficient for HIV-1 Gag
lattice trapping and incorporation.
J Virol. 2025 Apr 15:e0210524. doi: 10.1128/jvi.02105. PubMedAbstract available
HUANG Y, Liang G, Wang T, Ma Y, et al Research strategies of the N-peptide fusion inhibitor: a promising direction for
discovering novel antivirals.
J Virol. 2025 Apr 10:e0228924. doi: 10.1128/jvi.02289. PubMedAbstract available
WU C, Johnson NM, Yu S, Lo AS, et al Persistence of CMV-specific anti-HIV CAR T cells after adoptive immunotherapy.
J Virol. 2025 Apr 10:e0193324. doi: 10.1128/jvi.01933. PubMedAbstract available
CHAUDHURI E, Jang S, Chakraborty R, Radhakrishnan R, et al CPSF6 promotes HIV-1 preintegration complex function.
J Virol. 2025 Apr 9:e0049025. doi: 10.1128/jvi.00490. PubMedAbstract available
VIOX EG, Richard J, Grandea AG 3rd, Nguyen K, et al Safety, pharmacokinetics, and biological activity of CD4-mimetic BNM-III-170 in
SHIV-infected rhesus macaques.
J Virol. 2025 Apr 7:e0006225. doi: 10.1128/jvi.00062. PubMedAbstract available
March 2025
CHATTERJEE D, Niu L, Medjahed H, Ding S, et al A gp41 HR2 residue modulates the susceptibility of HIV-1 envelope glycoproteins
to small molecule inhibitors targeting gp120.
J Virol. 2025 Mar 27:e0226724. doi: 10.1128/jvi.02267. PubMedAbstract available
YAN H, Gao Y, Zhu Y, Chong H, et al Addition of a short HIV-1 fusion-inhibitory peptide to PRO 140 antibody
dramatically increases its antiviral breadth and potency.
J Virol. 2025 Mar 25:e0201824. doi: 10.1128/jvi.02018. PubMedAbstract available
VICTORIA S, Leyens J, Meckes LM, Vavouras Syrigos G, et al CD4+ T cells facilitate replication of primary HIV-1 strains in macrophages and
formation of macrophage internal virus-containing compartments.
J Virol. 2025 Mar 25:e0018225. doi: 10.1128/jvi.00182. PubMedAbstract available
HSIEH S-H, Huang K-J, Wang C-T A virus-like particle assembly system for probing the HIV-1 Gag-Pol dimerization
domain: supporting evidence for reverse transcriptase involvement in protease
activation by influencing Gag-Pol/Gag-Pol interaction.
J Virol. 2025 Mar 12:e0223624. doi: 10.1128/jvi.02236. PubMedAbstract available
TURNER A-MW, Bashore FM, Falcinelli SD, Fox JA, et al BET degraders reveal BRD4 disruption of 7SK and P-TEFb is critical for effective
reactivation of latent HIV in CD4+ T-cells.
J Virol. 2025 Mar 11:e0177724. doi: 10.1128/jvi.01777. PubMedAbstract available
GC K, Lesko S, Emery A, Burnett C, et al HIV-1 single-transcription start-site mutants display complementary replication
functions that are restored by reversion.
J Virol. 2025 Mar 4:e0213924. doi: 10.1128/jvi.02139. PubMedAbstract available
JANEVSKA M, Witkowski W, Vermeire J, Borowicz M, et al Impairment of endocytosis-related factors FNBP1L, ARHGAP24, and ATP6V1B1
increases HIV-1 entry into dendritic cells.
J Virol. 2025 Mar 3:e0206624. doi: 10.1128/jvi.02066. PubMedAbstract available
February 2025
GOLAS G, Park BS, Wong SW Glycoproteins gM and gN are indispensable factors for rhesus macaque rhadinovirus
replication and spread but can be reconstituted by KSHV chimeras.
J Virol. 2025 Feb 25:e0192224. doi: 10.1128/jvi.01922. PubMedAbstract available
GUERRERO JF, Zimdars LL, Bruce JW, Becker JT, et al Single-cell delineation of strain-specific HIV-1 Vif activities using dual
reporter sensor cells and live cell imaging.
J Virol. 2025 Feb 25:e0157924. doi: 10.1128/jvi.01579. PubMedAbstract available
XU M, Hu H, Yang W, Zhang J, et al FBXO45 restricts HIV-1 replication by inducing SQSTM1/p62-mediated autophagic
degradation of Tat.
J Virol. 2025 Feb 12:e0191224. doi: 10.1128/jvi.01912. PubMedAbstract available
WILLIAMS EP, Xue Y, Vogel P, Yang D, et al The antiviral BDGR-49 provides protection from lethal, neurotropic Venezuelan
equine encephalitis virus intranasal infection in mice.
J Virol. 2025 Feb 12:e0167924. doi: 10.1128/jvi.01679. PubMedAbstract available
MITCHELL JL, Buranapraditkun S, Gantner P, Takata H, et al Activation of CXCR3(+) Tfh cells and B cells in lymph nodes during acute HIV-1
infection correlates with HIV-specific antibody development.
J Virol. 2025 Feb 11:e0153224. doi: 10.1128/jvi.01532. PubMedAbstract available
LI M, Yu F, Zhu B, Xiao J, et al Interactions between human immunodeficiency virus and human endogenous
retroviruses.
J Virol. 2025 Feb 7:e0231924. doi: 10.1128/jvi.02319. PubMedAbstract available
ANG CG, Hyatt NL, Le Minh G, Gupta M, et al Conformational activation and disulfide exchange in HIV-1 Env induce cell-free
lytic/fusogenic transformation and enhance infection.
J Virol. 2025 Feb 6:e0147124. doi: 10.1128/jvi.01471. PubMedAbstract available
HUDSON A, Wu P, Kroll KW, Hueber B, et al Longitudinal analysis of rhesus macaque metabolome during acute SIV infection
reveals disruption in broad metabolite classes.
J Virol. 2025 Feb 6:e0163424. doi: 10.1128/jvi.01634. PubMedAbstract available
JANSSENS J, Wedrychowski A, Kim SJ, Isbell C, et al Longitudinal changes in the transcriptionally active and intact HIV reservoir
after starting ART during acute infection.
J Virol. 2025 Feb 5:e0143124. doi: 10.1128/jvi.01431. PubMedAbstract available
PASCOE RD, Kim Y, Rhodes A, Ong J, et al Targeting Ikaros and Aiolos with pomalidomide fails to reactivate or induce
apoptosis of the latent HIV reservoir.
J Virol. 2025 Feb 4:e0167624. doi: 10.1128/jvi.01676. PubMedAbstract available
January 2025
KAJASTE-RUDNITSKI A, Marelli SS, Pultrone C, Pertel T, et al Correction for Kajaste-Rudnitski et al., "TRIM22 Inhibits HIV-1 Transcription
Independently of Its E3 Ubiquitin Ligase Activity, Tat, and NF-kappaB-Responsive Long
Terminal Repeat Elements".
J Virol. 2025 Jan 27:e0207124. doi: 10.1128/jvi.02071. PubMed
ARA A, Love RP, Follack TB, Ahmed KA, et al Erratum for Ara et al., "Mechanism of Enhanced HIV Restriction by Virion
Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G".
J Virol. 2025 Jan 16:e0220424. doi: 10.1128/jvi.02204. PubMed
FAYYAZ S, Lotke R, Haussmann I, Petersen M, et al Reactivation of latent HIV-1 by the glucocorticoid receptor modulator AZD9567.
J Virol. 2025 Jan 16:e0188624. doi: 10.1128/jvi.01886. PubMedAbstract available
COHEN P, Lambson BE, Mkhize NN, Moodley C, et al Resistance mutations that distinguish HIV-1 envelopes with discordant VRC01
phenotypes from multi-lineage infections in the HVTN703/HPTN081 trial:
implications for cross-resistance.
J Virol. 2025 Jan 16:e0173024. doi: 10.1128/jvi.01730. PubMedAbstract available
LICHON DM, LoMascolo NJ, Mounce BC, Campbell EM, et al Microtubule acetylation is not required for HIV-1 infection or TRIM69-mediated
restriction of HIV-1 infection.
J Virol. 2025 Jan 13:e0102624. doi: 10.1128/jvi.01026. PubMedAbstract available
December 2024
COUNCIL OD, Tyers L, Moeser M, Sondgeroth A, et al The persistent pool of HIV-1-infected cells is formed episodically during
untreated infection.
J Virol. 2024 Dec 26:e0097924. doi: 10.1128/jvi.00979. PubMedAbstract available
GABA A, Yousefi M, Bhattacharjee S, Chelico L, et al Variability in HIV-1 transmitted/founder virus susceptibility to combined
APOBEC3F and APOBEC3G host restriction.
J Virol. 2024 Dec 23:e0160624. doi: 10.1128/jvi.01606. PubMedAbstract available
CHEN C, Zhong Z, Zhang W, Xia B, et al Tannic acid reactivates HIV-1 latency by mediating CBX4 degradation.
J Virol. 2024 Dec 18:e0117324. doi: 10.1128/jvi.01173. PubMedAbstract available
CHEN K, Zhou B, Wang X, Yang G, et al Equine lentivirus Gag protein degrades mitochondrial antiviral signaling protein
via the E3 ubiquitin ligase Smurf1.
J Virol. 2024 Dec 12:e0169124. doi: 10.1128/jvi.01691. PubMedAbstract available
CUI W, Wang H, Gao Y, Zhang X, et al Deubiquitinase USP37 enhances the anti-HIV-2/SIV ability of the host restriction
factor SAMHD1.
J Virol. 2024 Dec 10:e0185824. doi: 10.1128/jvi.01858. PubMedAbstract available
TAKAHAMA S, Washizaki A, Okamura T, Kitamura S, et al The quality of SIV-specific fCD8 T cells limits SIV RNA production in Tfh cells
during antiretroviral therapy.
J Virol. 2024 Dec 6:e0081224. doi: 10.1128/jvi.00812. PubMedAbstract available
November 2024
DING H, Nguyen HT, Li W, Deshpande A, et al Inducible cell lines producing replication-defective human immunodeficiency virus
particles containing envelope glycoproteins stabilized in a pretriggered
conformation.
J Virol. 2024 Nov 7:e0172024. doi: 10.1128/jvi.01720. PubMedAbstract available
STEVENS CS, Carmichael JC, Watkinson R, Kowdle S, et al A temperature-sensitive and less immunogenic Sendai virus for efficient gene
editing.
J Virol. 2024 Nov 4:e0083224. doi: 10.1128/jvi.00832. PubMedAbstract available
October 2024
PADRON A, Dwivedi R, Chakraborty R, Prakash P, et al Cyclophilin A facilitates HIV-1 integration.
J Virol. 2024 Oct 31:e0094724. doi: 10.1128/jvi.00947. PubMedAbstract available
HE W-Q, Pang W, Li N, Li A-Q, et al IFI27 inhibits HIV-1 replication by degrading Gag protein through the
ubiquitin-proteasome pathway.
J Virol. 2024 Oct 30:e0135624. doi: 10.1128/jvi.01356. PubMedAbstract available
LADINSKY MS, Zhu L, Ullah I, Uchil PD, et al Electron tomography visualization of HIV-1 virions trapped by fusion inhibitors
to host cells in infected tissues.
J Virol. 2024 Oct 30:e0143224. doi: 10.1128/jvi.01432. PubMedAbstract available
HOGAN VA, Harmon J, Cid-Rosas M, Hall LR, et al Conserved residues of the immunosuppressive domain of MLV are essential for
regulating the fusion-critical SU-TM disulfide bond.
J Virol. 2024 Oct 29:e0098924. doi: 10.1128/jvi.00989. PubMedAbstract available
September 2024
CHENG Z, Islam S, Kanlong JG, Sheppard M, et al Translation of HIV-1 unspliced RNA is regulated by 5' untranslated region
structure.
J Virol. 2024 Sep 24:e0116024. doi: 10.1128/jvi.01160. PubMedAbstract available
PINCUS SH, Cole FM, Ober K, Tokmina-Lukaszewska M, et al Conjugation of anti-HIV gp41 monoclonal antibody to a drug capable of targeting
resting lymphocytes produces an effective cytotoxic anti-HIV immunoconjugate.
J Virol. 2024 Sep 16:e0064724. doi: 10.1128/jvi.00647. PubMedAbstract available
JANEVSKA M, Cammaert T, Naessens E, Verhasselt B, et al A cGAS-mediated type I interferon response in human CD4+ T cells depends on
productive infection and is conserved over HIV types and strains.
J Virol. 2024 Sep 13:e0087724. doi: 10.1128/jvi.00877. PubMedAbstract available
ZANKHARIA U, Yi Y, Lu F, Vladimirova O, et al HIV-induced RSAD2/Viperin supports sustained infection of monocyte-derived
macrophages.
J Virol. 2024 Sep 11:e0086324. doi: 10.1128/jvi.00863. PubMedAbstract available
MARCHITTO L, Richard J, Prevost J, Tauzin A, et al The combination of three CD4-induced antibodies targeting highly conserved Env
regions with a small CD4-mimetic achieves potent ADCC activity.
J Virol. 2024 Sep 9:e0101624. doi: 10.1128/jvi.01016. PubMedAbstract available
ZHANG S, Anang S, Zhang Z, Nguyen HT, et al Conformations of membrane human immunodeficiency virus (HIV-1) envelope
glycoproteins solubilized in Amphipol A18 lipid-nanodiscs.
J Virol. 2024 Sep 9:e0063124. doi: 10.1128/jvi.00631. PubMedAbstract available
AGRAWAL P, Knudsen ML, MacCamy A, Hurlburt NK, et al Short CDRL1 in intermediate VRC01-like mAbs is not sufficient to overcome key
glycan barriers on HIV-1 Env.
J Virol. 2024 Sep 6:e0074424. doi: 10.1128/jvi.00744. PubMedAbstract available
TAUZIN A, Marchitto L, Belanger E, Benlarbi M, et al Three families of CD4-induced antibodies are associated with the capacity of
plasma from people living with HIV to mediate ADCC in the presence of
CD4-mimetics.
J Virol. 2024 Sep 4:e0096024. doi: 10.1128/jvi.00960. PubMedAbstract available
ZHANG W, Nilles TL, Bream JH, Li H, et al Breadth and polyfunctionality of T cell responses to human cytomegalovirus in men
who have sex with men: relationship with HIV infection and frailty.
J Virol. 2024 Sep 4:e0116724. doi: 10.1128/jvi.01167. PubMedAbstract available
August 2024
BRACKENRIDGE S, John N, He W, Fruh K, et al Regulation of the cell surface expression of classical and non-classical MHC
proteins by the human cytomegalovirus UL40 and rhesus cytomegalovirus Rh67
proteins.
J Virol. 2024 Aug 29:e0120624. doi: 10.1128/jvi.01206. PubMedAbstract available
ZHANG Y, Zhang M, Wu H, Wu X, et al Afucosylated anti-EBOV antibody MIL77-3 engages sGP to elicit NK cytotoxicity.
J Virol. 2024 Aug 20:e0068524. doi: 10.1128/jvi.00685. PubMedAbstract available
BARBOSA BOMFIM CC, Genin H, Cottoignies-Callamarte A, Gallois-Montbrun S, et al CGRP inhibits SARS-CoV-2 infection of bronchial epithelial cells, and its
pulmonary levels correlate with viral clearance in critical COVID-19 patients.
J Virol. 2024 Aug 20:e0012824. doi: 10.1128/jvi.00128. PubMedAbstract available
MUECKSCH F, Klaus S, Laketa V, Muller B, et al Probing Gag-Env dynamics at HIV-1 assembly sites using live-cell microscopy.
J Virol. 2024 Aug 13:e0064924. doi: 10.1128/jvi.00649. PubMedAbstract available
MU Z, Whitley J, Martik D, Sutherland L, et al Comparison of the immunogenicity of mRNA-encoded and protein HIV-1 Env-ferritin
nanoparticle designs.
J Virol. 2024 Aug 13:e0013724. doi: 10.1128/jvi.00137. PubMedAbstract available
July 2024
ZHOU M, Yang T, Yuan M, Li X, et al ORC1 enhances repressive epigenetic modifications on HIV-1 LTR to promote HIV-1
latency.
J Virol. 2024 Jul 31:e0003524. doi: 10.1128/jvi.00035. PubMedAbstract available
NELSON GW, van Duijn J, Yuki Y, Pau MG, et al Prediction of differential Gag versus Env responses to a mosaic HIV-1 vaccine
regimen by HLA class I alleles.
J Virol. 2024 Jul 24:e0028124. doi: 10.1128/jvi.00281. PubMedAbstract available
REYES BALLISTA JM, Hoover AJ, Noble JT, Acciani MD, et al Chikungunya virus release is reduced by TIM-1 receptors through binding of
envelope phosphatidylserine.
J Virol. 2024 Jul 15:e0077524. doi: 10.1128/jvi.00775. PubMedAbstract available
June 2024
KUSE N, Noyori O, Takahashi N, Zhang Y, et al Recognition of HIV-1-infected fibrocytes lacking Nef-mediated HLA-B
downregulation by HIV-1-specific T cells.
J Virol. 2024 Jun 28:e0079124. doi: 10.1128/jvi.00791. PubMedAbstract available
ROESMANN F, Sertznig H, Klaassen K, Wilhelm A, et al The interferon-regulated host factor hnRNPA0 modulates HIV-1 production by
interference with LTR activity, mRNA trafficking, and programmed ribosomal
frameshifting.
J Virol. 2024 Jun 20:e0053424. doi: 10.1128/jvi.00534. PubMedAbstract available
BOOPATHY AV, Nekkalapudi A, Sung J, Schulha S, et al Flt3 agonist enhances immunogenicity of arenavirus vector-based simian
immunodeficiency virus vaccine in macaques.
J Virol. 2024 Jun 3:e0029424. doi: 10.1128/jvi.00294. PubMedAbstract available
May 2024
NAZZIWA J, Andrews SM, Hou MM, Bruhn CAW, et al Higher HIV-1 evolutionary rate is associated with cytotoxic T lymphocyte escape
mutations in infants.
J Virol. 2024 May 30:e0007224. doi: 10.1128/jvi.00072. PubMedAbstract available
DEKKER JG, Klaver B, Berkhout B, Das AT, et al Reverse transcription of HIV-1 2-LTR circle transcripts does frequently cause
3'-polypurine tract mutations implicated in dolutegravir resistance.
J Virol. 2024 May 24:e0033524. doi: 10.1128/jvi.00335. PubMed
RAHMBERG AR, Markowitz TE, Mudd JC, Ortiz AM, et al SIV infection and ARV treatment reshape the transcriptional and epigenetic
profile of naive and memory T cells in vivo.
J Virol. 2024 May 23:e0028324. doi: 10.1128/jvi.00283. PubMedAbstract available
WEBB GM, Pessoa CT, McCullen AJ, Hwang JM, et al Immune restoration by TIGIT blockade is insufficient to control chronic SIV
infection.
J Virol. 2024 May 22:e0027324. doi: 10.1128/jvi.00273. PubMedAbstract available
VERBEEK R, Vandekerckhove L, Van Cleemput J Update on human herpesvirus 7 pathogenesis and clinical aspects as a roadmap for
future research.
J Virol. 2024 May 8:e0043724. doi: 10.1128/jvi.00437. PubMedAbstract available
April 2024
PERSAUD AT, Khela J, Fernandes C, Chaphekar D, et al Virion-incorporated CD14 enables HIV-1 to bind LPS and initiate TLR4 signaling in
immune cells.
J Virol. 2024 Apr 25:e0036324. doi: 10.1128/jvi.00363. PubMedAbstract available
YANG Q, Wang J, Chen Z Conditional splicing system for tight control of viral overlapping genes.
J Virol. 2024;98:e0024224. PubMedAbstract available
March 2024
VON MALTITZ P, Wettstein L, Weil T, Schommers P, et al Semen enhances transmitted/founder HIV-1 infection and only marginally reduces
antiviral activity of broadly neutralizing antibodies.
J Virol. 2024 Mar 19:e0119023. doi: 10.1128/jvi.01190. PubMedAbstract available
TWENTYMAN J, Emerman M, Ohainle M Capsid-dependent lentiviral restrictions.
J Virol. 2024 Mar 18:e0030824. doi: 10.1128/jvi.00308. PubMedAbstract available
February 2024
JOSHI VR, Claiborne DT, Pack ML, Power KA, et al A VRC13-like bNAb response is associated with complex escape pathways in HIV-1
envelope.
J Virol. 2024 Feb 27:e0172023. doi: 10.1128/jvi.01720. PubMedAbstract available